-
Founded in:
1999-04-21 -
Country:
China -
Address:
No. 889, Century Avenue, Economic Development Zone, Quzhou City, Zhejiang Province -
Tax NO.:
913308007302963689 -
Registered Funds:
52.083333 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| SOPHORAE FLAVESCENTIS RADIX |
|
0 | ||
| Cnidii Fructus |
|
0 | ||
| Chrysophanic acid |
|
481-74-3 | 0 | |
| STEMONAE RADIX |
|
0 | ||
| MUME FRUCTUS |
|
0 | ||
| Sodium tetraborate decahydrate |
|
1303-96-4 | 15 | |
| Borneol |
|
507-70-0 | 1 | |
| Aluminium potassium sulfate dodecahydrate |
|
7784-24-9 | 3 | |
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rhodiola Crenulate(tibetan Ginseng) Salidroside 1-5%,Rosavins 3% HPLC |
|
0 | ||
| lycii Fructus |
|
0 | ||
| Sea buckthorn juice |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gliclazide |
This drug is a hypoglycemic sulfonylurea-oral diabetes treatment drug. Gliclazide lowers blood sugar levels by stimulating pancreatic β cells to secrete insulin. For type 2 diabetes, gliclazide can restore the first-phase insulin secretion peak in response to glucose and increase the second-phase insulin secretion. It can be seen that the insulin secretion response induced or stimulated by glucose after a meal is significantly increased.
More
This drug is a hypoglycemic sulfonylurea-oral diabetes treatment drug. Gliclazide lowers blood sugar levels by stimulating pancreatic β cells to secrete insulin. For type 2 diabetes, gliclazide can restore the first-phase insulin secretion peak in response to glucose and increase the second-phase insulin secretion. It can be seen that the insulin secretion response induced or stimulated by glucose after a meal is significantly increased. |
21187-98-4 | 22 |